MicroRNA, hsa-miR-200c, is an independent prognostic factor in pancreatic cancer and its upregulation inhibits pancreatic cancer invasion but increases cell proliferation
By: Jun Yu , Kenoki Ohuchida , Kazuhiro Mizumoto , Norihiro Sato , Tadashi Kayashima , Hayato Fujita , Kouhei Nakata and Masao Tanaka

Molecular Cancer 2010, 9:169 doi:10.1186/1476-4598-9-169
Published: 28 June 2010

Abstract (Provisional)

Background

Recently, the microRNA-200 family was reported to affect cancer biology by regulating epithelial to mesenchymal transition (EMT). Especially, the expression of miR-200c has been shown to be associated with upregulating the expression of E-cadherin, a gene known to be involved in pancreatic cancer behavior. However, the significance of miR-200c in pancreatic cancer is unknown.

Methods

In the present study, we investigated the relationship between E-cadherin and miR-200c expression in a panel of 14 pancreatic cancer cell lines and in macro-dissected formalin-fixed paraffin-embedded (FFPE) tissue samples obtained from 99 patients who underwent pancreatectomy for pancreatic cancer. We also investigated the effects of miR-200c on the proliferation and invasion of pancreatic cancer cells.

Results

We found that patients with high levels of miR-200c expression had significantly better survival rates than those with low levels of miR-200c expression. We also found a remarkably strong correlation between the levels of miR-200c and E-cadherin expression.

Conclusions

These data indicate that miR-200c may play a role in the pancreatic cancer biology and may be a novel marker for the prognosis of pancreatic cancer.

The complete article is available as a provisional PDF. The fully formatted PDF and HTML versions are in production







Copyright 2026 InterMDnet | Privacy Policy | Disclaimer | System Requirements